Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor | Zendy

Chiara Spertilli Raffaelli | Zendy; Barbara Rossetti | Zendy; Lorenzo Paglicci | Zendy; Manuela Colafigli | Zendy; Grazia Punzi | Zendy; Vanni Borghi | Zendy; Monica Pecorari | Zendy; Maria Mercedes Santoro | Zendy; Giovanni Penco | Zendy; Andrea Antinori | Zendy; Maurizio Zazzi | Zendy; Andrea De Luca | Zendy; Giacomo Zanelli | Zendy

Open Access

Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor

Author(s) -

Chiara Spertilli Raffaelli,

Barbara Rossetti,

Lorenzo Paglicci,

Manuela Colafigli,

Grazia Punzi,

Vanni Borghi,

Monica Pecorari,

Maria Mercedes Santoro,

Giovanni Penco,

Andrea Antinori,

Maurizio Zazzi,

Andrea De Luca,

Giacomo Zanelli

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky211

Subject(s) - integrase , hazard ratio , drug resistance , medicine , hiv drug resistance , integrase inhibitor , viral load , virology , gastroenterology , human immunodeficiency virus (hiv) , pharmacology , antiretroviral therapy , biology , confidence interval , microbiology and biotechnology

To examine the impact of transmitted drug resistance (TDR) on response to first-line regimens with integrase strand transfer inhibitors (INSTIs) or boosted protease inhibitors (bPIs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research